Cardiovascular-Kidney-Metabolic Risk and Grade 3 Hepatic Steatosis in a Young Adult With Morbid Obesity: A Primary Care Case
Turkish Journal of Family Medicine and Primary Care · 19.11.2026 · (Advanced Online Publication) · 1-5
DOI: 10.21763/tjfmpc.1958048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Family Medicine and Primary Care, online erschienen am 19.11.2026. Verfasst von Murat Kılıç und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Gefördert von: No financial support was received for this study..
Abstract (Originalsprache)
Obesity is a multisystem disease with cardiovascular, kidney, metabolic, and hepatic consequences. We report clustered cardiovascular-kidney-metabolic (CKM) risk detected through opportunistic screening in a 32-year-old man who presented to primary care with allergic symptoms and had no known chronic disease. He was a long-distance truck driver who had smoked one pack per day for approximately 10 years, consumed about one alcoholic drink per week, reported no physical activity, and followed a predominantly fast-food-based diet. His height was 173 cm, weight 143 kg, body mass index 47.8 kg/m², waist circumference 148 cm, office blood pressure 150/90 and 146/95 mmHg, and pulse 85 beats/min. Physical examination revealed acanthosis nigricans. Initial testing showed fasting glucose 106 mg/dL, HbA1c 5.8%, fasting insulin 27.3 µIU/mL, HOMA-IR 7.1, alanine aminotransferase 61.6 U/L, and low-density lipoprotein cholesterol 114.4 mg/dL. Approximately three weeks later, insulin resistance persisted, triglycerides were 173 mg/dL, alanine aminotransferase 59.8 U/L, and gamma-glutamyl transferase 61 U/L. Ultrasonography showed hepatomegaly (200 mm) and grade 3 hepatic steatosis. With preserved kidney function, the overall phenotype was suggestive of American Heart Association CKM stage 2 rather than a definitive diagnosis of advanced CKM disease. The patient was referred to internal medicine; dietary intervention and weight reduction were recommended, and blood pressure and metabolic follow-up were planned. No pharmacological treatment was initiated in primary care. This case highlights the value of opportunistic chronic disease screening in primary care among young adults with morbid obesity who have no cardiometabolic symptoms.
Förderung
- No financial support was received for this study.
Zitieren
APA
Kılıç, M., & Kılıç, B. (2026). Cardiovascular-Kidney-Metabolic Risk and Grade 3 Hepatic Steatosis in a Young Adult With Morbid Obesity: A Primary Care Case. Turkish Journal of Family Medicine and Primary Care, 1-5. https://doi.org/10.21763/tjfmpc.1958048
Vancouver
Kılıç M, Kılıç B. Cardiovascular-Kidney-Metabolic Risk and Grade 3 Hepatic Steatosis in a Young Adult With Morbid Obesity: A Primary Care Case. Turkish Journal of Family Medicine and Primary Care. 2026:1-5. doi:10.21763/tjfmpc.1958048
BibTeX
@article{Kl2026,
author = {Kılıç, Murat and Kılıç, Burcu},
title = {Cardiovascular-Kidney-Metabolic Risk and Grade 3 Hepatic Steatosis in a Young Adult With Morbid Obesity: A Primary Care Case},
journal = {Turkish Journal of Family Medicine and Primary Care},
year = {2026},
number = {Advanced Online Publication},
pages = {1--5},
doi = {10.21763/tjfmpc.1958048}
}
EUVIMED